Published in Arch Biochem Biophys on October 01, 1992
The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity. J Bacteriol (1999) 1.32
Characterization of nicotinamide mononucleotide adenylyltransferase from thermophilic archaea. J Bacteriol (1997) 1.07
Molecular characterization of organelle-type Nudix hydrolases in Arabidopsis. Plant Physiol (2008) 1.02
NMN adenylyltransferase from bull testis: purification and properties. Biochem J (1995) 0.88
Mitochondria-localized NAD biosynthesis by nicotinamide mononucleotide adenylyltransferase in Jerusalem artichoke (Helianthus tuberosus L.) heterotrophic tissues. Planta (2011) 0.77
Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repair. Br J Cancer (1997) 0.75
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet (1998) 2.07
Enzymology of NAD+ synthesis. Adv Enzymol Relat Areas Mol Biol (1999) 1.84
End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J (2007) 1.84
Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci (2004) 1.80
Regulation of glutamine synthetase adenylylation and deadenylylation by the enzymatic uridylylation and deuridylylation of the PII regulatory protein. Arch Biochem Biophys (1973) 1.78
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ (2006) 1.68
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65
Spectroscopic characterization of mineralogy and its diversity across Vesta. Science (2012) 1.57
Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency. Blood (2001) 1.52
Side-effects of subcutaneous apomorphine in Parkinson's disease. Lancet (1989) 1.52
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. J Clin Psychopharmacol (1999) 1.50
The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity. J Bacteriol (1999) 1.32
Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem (2001) 1.28
Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry (1997) 1.22
Chronic pelvic pain and depression. Psychopathology (1984) 1.14
A prospective randomized double-blinded controlled study of ropivacaine 0.75% versus bupivacaine 0.5%-mepivacaine 2% for peribulbar anesthesia. Reg Anesth Pain Med (2000) 1.13
An estimation of Toxocara canis prevalence in dogs, environmental egg contamination and risk of human infection in the Marche region of Italy. Vet Parasitol (2003) 1.13
E. coli recA protein possesses a strand separating activity on short duplex DNAs. EMBO J (1985) 1.12
Synechocystis sp. slr0787 protein is a novel bifunctional enzyme endowed with both nicotinamide mononucleotide adenylyltransferase and 'Nudix' hydrolase activities. FEBS Lett (1999) 1.11
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J Clin Psychiatry (1995) 1.10
Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal Biochem (1995) 1.09
Sleep disorders in Parkinson's disease. J Neurol (1998) 1.09
Characterization of nicotinamide mononucleotide adenylyltransferase from thermophilic archaea. J Bacteriol (1997) 1.07
Identification and characterization of YLR328W, the Saccharomyces cerevisiae structural gene encoding NMN adenylyltransferase. Expression and characterization of the recombinant enzyme. FEBS Lett (1999) 1.06
Antioxidant properties of Mediterranean spices compared with common food additives. J Food Prot (2001) 1.05
Structure of nicotinamide mononucleotide adenylyltransferase: a key enzyme in NAD(+) biosynthesis. Structure (2000) 1.05
A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology (1989) 1.05
Short-term effects of olanzapine in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol (2001) 1.05
Thymosin beta 10, a new analog of thymosin beta 4 in mammalian tissues. Arch Biochem Biophys (1983) 1.02
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome. Am J Med Genet (1998) 0.99
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry (1997) 0.99
Recurrent abdominal pain in children: a long term follow-up. Eur J Pediatr (1987) 0.99
Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr Med Chem (2004) 0.98
Recombinant human cytidine deaminase: expression, purification, and characterization. Protein Expr Purif (1996) 0.98
Lipids of whole cells and plasma membrane fractions from Balb/c3T3, SV3T3, and concanavalin A-selected revertant cells. J Lipid Res (1979) 0.97
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler (2013) 0.97
Effect of essential fatty acid deficiency on the lipid composition of the Yoshida ascites hepatoma (AH 130) and of the liver and blood plasma from host and normal rats. J Lipid Res (1976) 0.96
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage (2002) 0.96
Chronic low-back pain and depression: an epidemiological survey. Acta Psychiatr Scand (1984) 0.96
Pramipexole in comparison to l-dopa: a neuropsychological study. J Neural Transm (Vienna) (2003) 0.96
Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties. J Biol Chem (1979) 0.96
Distribution of thymosin beta 4 in vertebrate classes. Arch Biochem Biophys (1983) 0.95
Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol (1997) 0.95
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. J Neural Transm (Vienna) (2001) 0.95
Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil (2008) 0.95
DSM-III diagnoses associated with dyspepsia of unknown cause. Am J Psychiatry (1987) 0.95
Isolation of yeast nuclei. Evidence of chromatin-associated proteolytic activity. Physiol Chem Phys (1982) 0.95
NAD(P) biosynthesis enzymes as potential targets for selective drug design. Curr Med Chem (2009) 0.94
Initiation, elongation and pausing of in vitro DNA synthesis catalyzed by immunopurified yeast DNA primase: DNA polymerase complex. EMBO J (1985) 0.94
X-linked mental retardation with marfanoid habitus: first report of four Italian patients. Am J Med Genet (1991) 0.93
Yolk formation and degradation during oocyte maturation in seabream Sparus aurata: involvement of two lysosomal proteinases. Biol Reprod (1999) 0.92
Psychological distress in parents of children with acute lymphatic leukemia. Acta Psychiatr Scand (1983) 0.92
A one-step procedure for the purification of uridine phosphorylase from Escherichia coli. Anal Biochem (1983) 0.92
Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis. Clin Genet (2000) 0.92
Pyridine dinucleotide biosynthesis in archaebacteria: presence of NMN adenylyltransferase in Sulfolobus solfataricus. FEBS Lett (1994) 0.92
Cognitive concomitants of dopamine system stimulation in parkinsonian patients. J Neurol Neurosurg Psychiatry (1987) 0.91
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group. Neurology (1999) 0.90
Phytotoxic protein PcF, purification, characterization, and cDNA sequencing of a novel hydroxyproline-containing factor secreted by the strawberry pathogen Phytophthora cactorum. J Biol Chem (2001) 0.90
Nicotinamide mononucleotide adenylyltransferase. Molecular and enzymatic properties of the homogeneous enzyme from baker's yeast. Biochemistry (1986) 0.90
Initiating therapy for Parkinson's disease. Neurology (1998) 0.89
Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol (1989) 0.89
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study. Clin Neuropharmacol (1994) 0.89
A psychosomatic approach to idiopathic recurrences of anterior uveitis. Am J Ophthalmol (1987) 0.89
NMN adenylyltransferase from bull testis: purification and properties. Biochem J (1995) 0.88
Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons. Brain Res (2006) 0.88
Uridine phosphorylase from Escherichia coli B. Enzymatic and molecular properties. Int J Biochem (1986) 0.88
Identification of the archaeal NMN adenylytransferase gene. Mol Cell Biochem (1999) 0.88